 |
Previous Article | Next Article 
Volume 17, Number 16,
Issue of August 15, 1997
pp. 6325-6337
Copyright ©1997 Society for Neuroscience
P2 Receptor Excitation of Rodent Hypoglossal Motoneuron Activity
In Vitro and In Vivo: A Molecular Physiological
Analysis
Gregory D. Funk,
Refik Kanjhan,
Carmen Walsh,
Janusz Lipski,
Alison M. Comer,
Marjorie A. Parkis, and
Gary D. Housley
Department of Physiology, Faculty of Medicine and Health Science,
University of Auckland, Auckland, New Zealand
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The role of P2 receptors in controlling hypoglossal motoneuron (XII
MN) output was examined (1) electrophysiologically, via application of
ATP to the hypoglossal nucleus of rhythmically active mouse medullary
slices and anesthetized adult rats; (2) immunohistochemically, using an
antiserum against the P2X2 receptor subunit; and (3) using
PCR to identify expression of P2X2 receptor subunits in
micropunches of tissue taken from the XII motor nucleus. Application of
ATP to the hypoglossal nucleus of mouse medullary slices and
anesthetized rats produced a suramin-sensitive excitation of
hypoglossal nerve activity. Additional in vitro effects
included potentiation of inspiratory hypoglossal nerve output via a
suramin- and pyridoxal-phosphate-6-azophenyl-2 ,4 -disulphonic
acid (PPADS)-sensitive mechanism, XII MN depolarization via activation
of a suramin-sensitive inward current, decreased neuronal input
resistance, and a slow-onset theophylline-sensitive reduction of
inspiratory output likely resulting from hydrolysis of extracellular
ATP to adenosine and activation of P1 receptors. Immunohistochemically,
P2X2 receptors were detected in inspiratory XII MNs that
were labeled with Lucifer yellow. These data, combined with
identification of mRNA for three P2X2 receptor subunit
isoforms within the hypoglossal nucleus (two of which have not been
localized previously in brain) and the previous demonstration that P2X
receptors are ubiquitously expressed in cranial and spinal motoneuron
pools, support not only a role of P2 receptors in modulating
inspiratory hypoglossal activity but a general role of P2 receptors in
modulating motor outflow from the CNS.
Key words:
respiration;
P2 receptor;
hypoglossal motoneuron;
ATP;
suramin;
PPADS;
adenosine;
medullary brain slice;
rat;
mouse
INTRODUCTION
ATP clearly has been established as a transmitter
within the CNS (Edwards et al., 1992 ; Evans et al., 1992 ; Salter et
al., 1993 ; Zimmerman, 1994 ; Burnstock, 1995 ). Its actions are mediated by two major receptor families (Abbracchio and Burnstock, 1994 ; Fredholm et al., 1994 ; Burnstock, 1995 ). P2X receptors are ligand-gated ion channels that mediate fast excitatory responses (Surprenant et al.,
1996 ). P2Y receptors mediate slower responses via G-proteins (Dubyak
and El-Moatassim, 1993 ; Burnstock, 1995 ). Purinergic synaptic signaling
in the CNS is complicated further by the extracellular hydrolysis of
ATP to adenosine, which modulates synaptic transmission via activation
of P1 receptors (Burnstock, 1995 ).
Widespread distribution of P2 receptors (Burnstock, 1995 ) in the brain,
indicated by autoradiographic (Bo and Burnstock, 1994 ; Balcar et al.,
1995 ), in situ hybridization (Kidd et al., 1995 ; Collo et
al., 1996 ; Kanjhan et al., 1996 ; Séguéla et al., 1996 ), and
immunohistochemical studies (Kanjhan et al., 1996 ; Vulchanova et al.,
1996 ), suggests involvement of ATP in many neuronal systems. It clearly
is involved in sensory transduction (Thorne and Housley, 1996 ), fast
excitatory neurotransmission (Edwards et al., 1992 ; Evans et al., 1992 ;
Harms et al., 1992 ; Tschöpl et al., 1992 ), modulation of
glutamatergic synaptic transmission (Li and Perl, 1995 ; Motin and
Bennett, 1995 ; Nakazawa et al., 1995 ), and modulation of norepinephrine
(NE) release (Burnstock and Sneddon, 1985 ; von Kügelgen et al.,
1994 ; Zimmerman, 1994 ; von Kügelgen, 1996 ) and is implicated in
central control of blood pressure (Sun et al., 1992 ; Day et al.,
1993 ).
An important role for ATP in motor control is suggested by the presence
of mRNA for several P2X receptor subunits within cranial and spinal
motor nuclei (Collo et al., 1996 ). As an initial step in elucidating
the role of ATP in controlling motoneuron activity, we examined the
effects of ATP on inspiratory hypoglossal nerve output in rhythmically
active neonatal mouse medullary slices and anesthetized adult rats.
Hypoglossal motoneuron (XII MN) activity was examined because (1) the
function of the XII nerve in maintaining upper airway patency is well
established (Remmers et al., 1978 ), allowing interpretation of the
effects of ATP in a well defined behavioral context; (2) inspiratory
drive to XII MNs is mediated primarily by glutamate (Greer et al.,
1991 ; Funk et al., 1993 ), and ATP modulates glutamatergic transmission
(Li and Perl, 1995 ; Motin and Bennet, 1995); (3) the XII motor nucleus
receives NE innervation (Levitt and Moore, 1979 ; Aldes et al., 1992 ),
and NE and ATP are colocalized in some synapses (Burnstock and Sneddon, 1985 ; Zimmerman, 1994 ); and (4) preliminary studies indicate an ATP
excitation of XII nerve activity in medullary slices (Funk, 1996 ), but
application of ATP to acutely dissociated adult XII MNs has no effect
(Ueno et al., 1996 ). We also examined the localization of
P2X2 receptors within the XII motor nucleus, using
immunohistochemical and PCR techniques. We focused on P2X2
receptors, not to exclude involvement of other P2 receptor subtypes but
because preliminary experiments (Funk, 1996 ) and previous
pharmacological and in situ hybridization data (Buell et
al., 1996 ; Collo et al., 1996 ) suggested that P2X2
receptors most likely were expressed in the XII nucleus.
MATERIALS AND METHODS
In vitro mouse experiments
Rhythmic medullary slices. In vitro
experiments were performed on transverse medullary slices from
postnatal day 0-3 (P0-P3) neonatal Swiss CD mice (n = 64) at 27°C. Details of procedures for obtaining slices are described
elsewhere (Funk et al., 1993 , 1994 ). Briefly, animals were anesthetized
with ether and decerebrated, and the brainstem-spinal cord were
isolated in control solution containing (in mM): 128 NaCl,
3.0 KCl, 1.5 CaCl2, 1.0 MgSO4, 21 NaHCO3, 0.5 NaH2PO4,
and 30 D-glucose equilibrated with
95%O2/5%CO2. The brainstem-spinal
cord was pinned down on a paraffin block and sectioned serially in the
transverse plane with a vibratome. Sectioning started from the rostral
medulla and continued to a point 150 µm rostral to the rostral
boundary of the pre-Bötzinger complex (Smith et al., 1991 ; Funk
et al., 1993 ). A 600 µm transverse slice was cut, transferred to a
recording chamber, and superfused continuously (40-45 ml/min) with
control solution containing 9 mM K+.
Population inspiratory activity was recorded bilaterally with suction
electrodes from XII nerve roots. These signals were amplified,
bandpass-filtered (0.1-3 kHz), rectified, integrated ( = 50 msec),
and recorded on chart recorder and video cassette via pulse code
modulation for measurement of frequency and burst amplitude of XII MN
population discharge.
Drug application. ATP-Na+ salt [1.0
mM, Research Biochemicals (RBI), Natick, MA],
ATP-Mg2+ salt (Sigma, St. Louis, MO), suramin (1.0 mM, RBI), adenosine (1.0 mM, RBI),
1,3,-dimethyl-8-phenylxanthine (theophylline, 100 µM,
RBI), and control solution (vehicle) were applied by timed pressure
injection (10 psi, 10-30 sec) from triple-barreled pipettes (6 µm
per barrel outside diameter). Pipette tips were placed within 25 µm
of the slice surface over the ventromedial aspect of the XII motor
nucleus. Preliminary experiments indicated that appropriate electrode
placement was critical for reducing response variability. ATP
application over the dorsal aspect of the XII nucleus produced tonic
excitation only. When it was injected over the ventromedial inspiratory
(Remmers et al., 1978 ; Krammer et al., 1979 ) aspect of the XII nucleus,
ATP consistently produced a significant increase of phasic inspiratory
activity as well as tonic excitation.
All experiments examining the effects of ATP on XII nerve output used 1 mM ATP. At 10 and 100 µM, ATP produced minor
excitation, whereas 10 mM ATP generated large increases in
tonic activity that made inspiratory activity difficult to resolve. ATP
applications of 30 sec encompassing five to seven inspiratory bursts
were used to assess effects of ATP on inspiratory burst amplitude. ATP
applications were reduced to 10 sec when suramin antagonism was tested
to minimize suramin application and to facilitate recovery. ATP also
was used at 1 mM during whole-cell recording experiments,
with the exception of those experiments performed in the presence of 1 µM bath-applied TTX for which 10 mM ATP was
used.
The concentrations and durations of drug application used in the
present study cannot be compared with those in experiments in which
similar agents were bath-applied or applied to isolated cells. First,
concentration of drug decreases exponentially with distance from the
pipette tip (Nicholson, 1985 ), and previous experiments with this
preparation indicate that drug concentration in the pipette must be
approximately one order of magnitude greater than the bath-applied
concentration to produce similar effects (Liu et al., 1990 ). Second,
diffusion barriers of thick slices slow response kinetics relative to
isolated cells. To speed the concentration buildup at neurons within
the slices, we used relatively high concentrations of ATP and
suramin.
In addition to local application of drugs via pressure injection,
pyridoxal-phosphate-6-azophenyl-2 ,4 -disulphonic acid (PPADS, 5 µM; RBI), a putative P2X-selective receptor antagonist
(Lambrecht et al., 1992 ; Trezise et al., 1994 ; Ziganshin et al., 1994 ;
Connolly, 1995 ), was applied directly to the medium bathing the slices. PPADS was administered via bath application because of the limited diffusion of PPADS into the tissue during the relatively brief exposure
periods associated with local application. In addition, the selectivity
of PPADS for P2X receptors may be concentration-dependent (Windscheif
et al., 1994 ), and bath application allows precise control over
antagonist concentration.
Analysis. Response time course was calculated by averaging
inspiratory burst amplitudes in 1 min bins for 2 min before drug application, in 30 sec bins for the first 2 min after onset of ATP
application, and in 1 min bins for the next 8 min. To discriminate between the effects of ATP on inspiratory burst amplitude and tonic
nerve activity, we corrected burst amplitude measurements for shifts in
baseline associated with increased tonic discharge. Suramin block was
assessed by comparing control/ATP responses with suramin/ATP responses.
In control responses ATP was applied during the last 10 sec of a 30 sec
control (vehicle) application. In suramin responses, ATP was applied
during the last 10 sec of a 30 sec suramin application.
Data are reported relative to preinjection values as mean ± SD.
Differences between means were tested with the statistical software
package SYSTAT 5.1, with ANOVA and multiple comparison tests. Values of
p < 0.05 were assumed significant.
Whole-cell recording. Intracellular recordings were made
from XII MNs with whole-cell patch-clamp recording techniques (Blanton et al., 1989 ). Patch electrodes (resistance, 4.0-4.5 M ; 1.5-2 µm
tip size) were pulled from borosilicate glass and filled with K+-gluconate solution containing (in
mM): 120 K+-gluconate, 5 NaCl, 1 CaCl2, 1 MgCl2, 10 HEPES (Sigma),
10 BAPTA (tetra K+ salt; Sigma), and 2 ATP
(Mg2+ salt) pH-adjusted to 7.3 with KOH. The
electrode solution also contained Lucifer yellow (dipotassium salt,
~0.1%; Sigma). Intracellular signals were amplified with a
patch-clamp amplifier (5 kHz low-pass filter; Axopatch 1D, Axon
Instruments, Foster City, CA).
Series resistance and whole-cell capacitance were estimated under
voltage-clamp conditions by using short voltage pulses (100 Hz, 10
mV, 3.0 msec). Series resistance (70-90% compensation with 10-20
µsec time lag) and membrane capacitance compensation were used.
Neuron input resistance (RN) was
calculated at a 60 mV holding potential from the current responses to
10 or 20 mV hyperpolarizing voltage steps (300 msec duration).
In vivo rat experiments
Adult Wistar rats (n = 5) were anesthetized with
sodium pentobarbital (Nembutal, 80 mg/kg, i.p., followed by 4-6 mg/hr,
i.v.), paralyzed with pancuronium bromide (Pavulon, 0.4 mg/hr), and
artificially ventilated with O2-enriched air. Tracheal
pressure (peak, <10 cm H2O), arterial blood pressure,
end-tidal CO2 (4.5-5.5%), and body temperature
(35-36°C) were monitored. The dorsal surfaces of the medulla
oblongata and cervical cord (C1-C7 segments) were exposed. Standard
bipolar electrodes were used to record from phrenic (unilaterally) and
XII nerves (bilaterally). These electrodes also were used to stimulate
XII nerves electrically (0.1 msec, 1.0-2.0 V) for antidromic
identification of XII nuclei.
The location of the XII motor nucleus was established by using glass
microelectrodes filled with 2 M NaCl (resistance 4-8 M ). An antidromic field potential after stimulation of the
ipsilateral XII nerve (see Fig. 6Ci) indicated electrode
placement within the XII nucleus. In three experiments, series of
tracks spaced 100 µm laterally were made at three rostrocaudal levels
(obex, 500 µm rostral, and 1000 µm rostral) to establish the
borders of the nucleus. After electrophysiological identification the NaCl electrode was removed, and a single-barrel drug ejection pipette
containing ATP was lowered into the same location. Drugs were
pressure-injected with 3.8 or 7.6 sec 10-16 psi pulses. Four to eight
bursts of inspiratory activity occurred during the period of ATP
application. After several ATP applications (see below), the ATP
pipette was removed and replaced with a suramin-containing pipette.
Suramin was applied, and then the suramin pipette was replaced with the
ATP pipette. Proper placement was guided during each exchange by the
use of surface landmarks and recording antidromic field potentials.
With this method pipette tip placement could be reproduced within <100
µm. Duration of drug application was limited in vivo
relative to in vitro to prevent pressure changes associated
with large injections inside tissue.
Fig. 6.
Excitation of XII nerve activity in
vivo. A, Tonic excitation of the ipsilateral XII
nerve activity after 7.6 sec application of 10 mM ATP into
the left XII nucleus under control conditions (i), 10 min after a 7.6 sec application of 10 mM suramin
(ii), and 30 min after suramin application
(iii). Traces represent integrated activity from the left and right XII nerve (LXII,
RXII), phrenic nerve (Phr), and
tracheal pressure (TP; calibration, 0-10 cm
H2O). B, Application of 10 mM
ATP into the rostral portion of the XII motor nucleus (1 mm rostral to
obex) potentiated inspiratory burst amplitude. (Note that burst
amplitude potentiation was observed in only 2 of 13 trials.)
Traces represent integrated activity from the left and
right XII nerve (LXII, RXII),
arterial blood pressure (BP; calibration, 100-200 mm
Hg), and raw phrenic nerve activity (Phr).
C, Antidromic field potentials generated by stimulation of the ipsilateral XII nerve and recorded within the hypoglossal motor
nucleus were used to indicate pipette placement (i).
ii, An example of inspiratory-related extracellular action
potentials (Unit) to verify ATP injection within the
vicinity of inspiratory-modulated XII MNs. D, Expanded
time scale recording showing the discharge envelope of inspiratory
activity recorded bilaterally from XII nerves and unilaterally from the
phrenic nerve (end-tidal CO2, 5.5%).
[View Larger Version of this Image (47K GIF file)]
The experimental paradigm involved electrophysiological identification
of the XII motor nucleus (described above), repeated local injections
of ATP (1.0-10 mM) to establish response reproducibility, suramin injection (1-10 mM), and repeated ATP injection to
test the effects of suramin on ATP responses and monitor recovery. Successive ATP applications were performed at a minimum of 5 min intervals. The effects of ATP on XII nerve discharge in vivo
were evaluated similarly to the analysis conducted in vitro,
using correction for shifts in baseline associated with increased tonic discharge.
Recordings were made with AC amplifiers (Neurolog NL 104/125, bandwidth
from 120 Hz to 6 kHz). All signals were monitored on a multichannel pen
recorder and oscilloscopes. Nerve output signals were rectified,
filtered ( = 100 msec), and recorded on a thermal array recorder
(Nikon Kohden, RTA-1100) and video cassette via pulse code
modulation.
Immunohistochemistry
Adult rats were anesthetized with sodium pentobarbital (120 mg/kg) and perfused transcardially with heparinized saline, followed by
4% formalin and 0.5% glutaraldehyde in 50 mM PBS, pH 7.4. Brainstems were removed and post-fixed in the same fixative for 48 hr
at 4°C. Free-floating transverse sections, cut with a vibratome (50 µm), underwent a 30 min preincubation with 1% bovine serum albumin (BSA; for details of P2X2R antiserum production and
characterization, see Kanjhan et al., 1996 ). Then the sections were
incubated with P2X2R 96 antiserum (1:2000-1:4000),
which had been pretreated with keyhole limpet hemocyanin (50 µg/ml;
Sigma). Subsequently, sections were incubated with biotinylated goat
anti-rabbit immunoglobulin (1:400; Sigma) and ExtrAvidin-peroxidase
conjugate (1:1000; Sigma). Antiserum was diluted in PBS containing 1%
BSA. All incubations were carried overnight at 4°C and were separated
by four washes in PBS. Sections were reacted with 0.5 mg/ml
3 ,3-diaminobenzidine tetrahydrochloride, 6 mg/ml ammonium nickel
sulfate, and 0.01% H2O2 in 50 mM
Tris-HCl buffer, pH 7.6, mounted on poly-L-lysine-subbed slides, dehydrated, cleared, and coverslipped with Histomount (Hughes
and Hughes). Control experiments in which primary antiserum was
excluded were run with each group. As an additional control for
antiserum specificity, the P2X2R96 antiserum was
preadsorbed with a synthetic peptide (50 µg/µl; Chiron, Australia)
corresponding to amino acids 96-113 of the putative extracellular
domain of the P2X2R subunit of the ATP-gated ion channel
(Brake et al., 1994 ). Then the immunoreactivity of the
P2X2R96 antiserum and peptide-blocked antiserum (both at
1:4000) were compared.
Neonatal mouse tissue was isolated as described below (in
vitro preparations) and post-fixed in 4% formalin and 0.5%
glutaraldehyde for 48 hr before cryosectioning (20 µm).
P2X2 receptor immunoreactivity was examined as described
above, except that the primary antibody was diluted at 1:100 and swine
anti-rabbit tetramethylrhodamine isothiocyanate (TRITC; 1:20; Dako,
High Wycombe, UK) conjugate was used as the secondary antibody.
Molecular characterization of P2X2 receptor gene
expression in the hypoglossal nucleus
Adult Wistar rats were anesthetized by carbon dioxide inhalation
and decapitated, and the brainstem was removed rapidly and frozen.
Micropunches of the hypoglossal nucleus from frozen 180- to
240-µm-thick transverse medullary sections were made with a 23 gauge
microdissection needle (Palkovits and Brownstein, 1988 ). Total RNA was
extracted by TriReagent (Molecular Research Center, Cincinnati, OH)
dissolved in 10 µl of H2O and reverse-transcribed in a
final volume of 20 µl containing 10 µl of RNA solution and (in
mM): 20 Tris-HCl, pH 8.4, 50 KCl, 1.5 MgCl2, and 1.25 dNTPs plus 1 µl of random
hexamers, 40 U of RNA guard (Pharmacia Biotech, Piscataway, NJ), and
200 U of SuperScript II (Life Technologies, Gaithersburg, MD). A
semi-nested PCR protocol was used to identify P2X2 receptor
subunits expressed in the tissue. First round PCR reactions were
performed in 50 µl volumes containing (in mM): 20 Tris-HCl, pH 8.4, 50 KCl, 2 MgCl2, and 0.25 dNTPs
plus 10 nM P2X2756s (CAC AGA ACT GGC ACA CAA
GG, relative to 5 position 756 of GenBank accession number U14414) and
P2X21558as (GGA CAT GGT TAC TGA AGA GCG, 5 position 1558 of GenBank accession number U14414) primers and 1.25 U of
Taq DNA polymerase (Life Technologies). Second round
amplifications were identical, except that alternative sense primers
were used and that the concentration of both primers was increased to
100 nM [sequences: P2X2S4 was CAG GTA GGG AGT
GGT TGG TAG, specific to the 85 bp insert splice variant of
P2X2R (Housley et al., 1995 ) (5 position 94 of GenBank accession number L43511); P2X2S1 was GCA TGG ACA GGC AGG
GAA AT (5 position 990 of GenBank accession number U14414); and P2X2S3 was CGG GGT GGG CTC CTT CCT GT (5 position 1059 of
GenBank number U14414)]. The thermal cycler (PTC-100, MJ Research, Watertown, MA) was programmed for 3 min at 94°C and then cycled through 30-35 cycles of 1 min denaturation (94°C), 2 min annealing (58-60°C), and 2.5 min extension (72°C). Aliquots of the PCR
products were run on a 1% agarose (Life Technologies)/1% NuSieve (FMC
Bioproducts, Rockland, ME) gel and visualized with ethidium bromide
under UV transillumination. The remaining PCR products were purified
either directly or from the agarose gel (QIAquick PCR purification kit or QIAquick gel extraction kit, Qiagen, Hilden, Germany) and
sequenced.
RESULTS
ATP mediates tonic excitation of hypoglossal activity and
potentiates inspiratory output in vitro
To test the effects of ATP on phasic (inspiratory) activity
recorded from XII nerves, we applied ATP locally over XII motor nuclei
of rhythmically active medullary slices. ATP application produced
potent excitation of XII nerve output, the onset and termination of
which coincided closely with the timing of the ATP application. The
response was composed of three distinct components: (1) tonic
excitation (present in 39 of 40 preparations), (2) potentiation of
inspiratory burst amplitude (39 of 40), and (3) inhibition of
inspiratory burst amplitude after the potentiation (29 of 40).
Tonic excitation, apparent as a thickening of the baseline in the raw
XII nerve recording (Fig. 1A) or a
shift in the baseline of the rectified, integrated trace (Fig.
1B), was exclusively unilateral (on the drug
application side) and typically peaked within the first 10 sec of the
application, decreasing slightly during the remainder of the
application. Superimposed on the tonic component was a significant
40 ± 20% ATP-mediated potentiation of inspiratory burst
amplitude (Fig. 1B,D) that was also exclusively unilateral and was followed in most cases by a slowly developing decrease in inspiratory burst amplitude. The inhibition peaked at 2 min
after the start of the ATP application with a decrease in burst
amplitude to 0.82 ± 0.05 of control. Single XII inspiratory bursts recorded before, during, and after ATP application are expanded
in Figure 1C. To ensure that the ATP-mediated excitation was
not attributable to chelation of divalent ions by ATP
(Na+ salts), we applied Mg2+
salts of ATP in four experiments. Mg2+ and
Na+ salts were equally effective at exciting XII
nerve output (data not shown).
Fig. 1.
Excitation of XII nerve activity in
vitro by ATP. A, Bilateral recordings of XII
nerve activity of a medullary slice from a postnatal day 2 mouse
showing the effects of 30 sec, 1 mM ATP injected
unilaterally over the ventromedial portion of the LXII nucleus.
Rhythmic bursts of activity represent inspiratory-related XII nerve
activity. B, Rectified and integrated signal of the raw
data traces and ATP response shown in A illustrates the
ATP-mediated potentiation of burst amplitude and subsequent decrease in
burst amplitude. Note the slower time scale in B.
C, The individual control (#), ATP (*), and post-ATP
(§) bursts indicated in B are shown in expanded form.
The baseline shift present during ATP application has been removed to
facilitate comparison of burst amplitude. D, Time course
of the changes in XII nerve inspiratory amplitude after local
application of 1 mM ATP to the ventromedial portion of the
XII motor nucleus (n = 20). Drug application
occurred at time = 0. Effects on contralateral XII
nerve output are documented also; asterisk indicates
significant difference from control levels.
[View Larger Version of this Image (42K GIF file)]
To confirm that the effects of ATP on XII nerve output were
attributable to the activation of P2 receptors, we examined the effects
of suramin (Fig. 2A). Suramin is a
general P2 antagonist that inhibits responses mediated by P2Y and
P2X2 receptors. A 30 sec application of suramin starting 20 sec before a 10 sec ATP application completely (n = 2)
or partially (n = 3; Fig. 2A, middle)
blocked the tonic excitation and the potentiation of inspiratory amplitude. Suramin was ineffective at blocking the post-ATP inhibition (Fig. 2A, middle). Partial to complete recovery from
suramin block was observed within 30 min of suramin application in all
(Fig. 2A, right) but one preparation.
Fig. 2.
Antagonism of ATP excitatory responses by suramin
and PPADS. A, The tonic excitatory and
amplitude-potentiating effects produced by ATP were reduced
significantly when ATP was applied for the last 10 sec of a 30 sec
suramin (1 mM) application, although the post-ATP
inhibition was not blocked (middle panel).
Inhibitory action of suramin was removed after 20 min of washout
(right panel). B, Bath application
of PPADS caused a significant reduction in the excitatory effects of
ATP without affecting the post-ATP decrease in inspiratory burst
amplitude (middle panel). The PPADS block of the
inspiratory burst amplitude-potentiating component of the ATP response
was reversible, given sufficient recovery time, whereas the tonic
excitatory effect did not show complete recovery even after 90 min of
washout. C, Time course of the changes in XII nerve
inspiratory burst amplitude after local application of ATP (1 mM) before, during, and after bath application of PPADS
(n = 5). ATP application occurred at time = 0; asterisk indicates significant
difference from amplitude values observed at the same time during the
control ATP application.
[View Larger Version of this Image (35K GIF file)]
The rapid onset and termination of the ATP-induced excitation suggested
involvement of P2X receptors in the ATP-induced excitation of XII nerve
output. Thus, ATP was applied in the presence of bath-applied PPADS (5 µM, 15 min equilibration period) to examine the role of
P2X receptors. PPADS virtually abolished the tonic excitatory component
of the ATP response (Fig. 2B, middle) and significantly reduced the potentiation of inspiratory burst amplitude by more than one-half from 33 ± 22 to 15 ± 16%
(n = 5; Fig. 2B, middle,
C). The post-ATP inhibitory response was unaffected by PPADS.
Recovery of the burst amplitude-potentiating component of the ATP
response from PPADS block was complete but slow, taking between 70 and
120 min (Fig. 2B, right). The tonic excitatory component of the ATP response, however, recovered only partially.
Local application of ATP over the XII motor nucleus would affect both
inspiratory as well as noninspiratory XII MNs and could produce its
effects pre- or postsynaptically. We therefore established whole-cell
recordings to test directly the effects of ATP on inspiratory XII MNs.
Inspiratory XII MNs received rhythmic synaptic inputs in phase with
each burst of activity on the XII nerve. Peak inward inspiratory
currents ranged from 25 to 300 pA and lasted 350-600 msec (Figs.
3, 4). ATP induced inward currents in all inspiratory XII MNs tested (n = 9; range 12 to 120 pA;
mean = 65 ± 50 pA) and two noninspiratory XII MNs
( 67 ± 42 pA). Similar to the XII nerve responses, the inward
current developed rapidly, peaked early in the application, and
decreased throughout the application in eight of nine cells. The ATP
currents were associated with a significant 13 ± 5% decrease in
neuronal input resistance from 108 to 94 M (n = 4),
were blocked by suramin (n = 2; Fig. 3B), and showed weak inward rectification (n = 2; Fig.
3A) in response to 2 sec voltage ramps between 100 and
45 mV.
Fig. 3.
ATP-mediated inward currents in inspiratory XII
MNs. A, A 30 sec application of 1 mM ATP
over XII motor nucleus produced tonic excitation of the nerve,
increased XII nerve inspiratory burst amplitude (top
trace, XII), and induced a 75 pA inward current in an
inspiratory XII MN. Voltage ramps ( 100 mV to 45 mV conducted over 2 sec) performed during control and ATP application (indicated by
asterisk) are plotted versus current. The ATP-induced
current, obtained by subtracting the control from the ATP curve
(ATP-Control), shows weak inward rectification.
B, Inward current induced by 10 sec of 1 mM
ATP is blocked by 30 sec preapplication of 1 mM suramin.
C, Inward current produced by 15 sec application of 10 mM ATP over inspiratory XII MN after bath application of
TTX. The current responses to 10 mV hyperpolarizing voltage steps
during control (Control) and during a subsequent
ATP application (ATP) indicated a decrease in input
resistance (right panel).
[View Larger Version of this Image (32K GIF file)]
Fig. 4.
Lucifer yellow-labeled inspiratory MN
(A) shows immunofluorescence for
P2X2R (B, arrow). The neuron
labeled in A and B responded to local
application of 1 mM ATP with a 75 pA inward current and a
decrease in input resistance (C). Inspiratory
synaptic currents recorded during control (#1), early
during ATP application (#2), and late in the ATP
application (#3) are shown with an expanded time scale
in D. Holding potential, 60 mV; peaks marked
synaptic currents represent 3 of 11 inspiratory synaptic
currents; asterisk equals 10 mV pulses for calculating
neuronal input resistance. Scale bar in A (applies to
B), 25 µm.
[View Larger Version of this Image (44K GIF file)]
Effects of ATP on inspiratory synaptic currents were variable and
time-dependent. Thus, the responses were analyzed by comparing the peak
inspiratory synaptic current averaged during control, during the first
20 sec of ATP application, and between 20 and 60 sec after onset of ATP
application in six neurons, the inward inspiratory synaptic currents of
which were >100 pA. Responses of one MN are shown at slow and expanded
time scales in Figure 4, C and D.
The tonic component of the ATP-induced current was subtracted in Figure
4D to facilitate comparison of the inspiratory synaptic currents before, during, and after ATP application. Four of
the six inspiratory MNs behaved like the neuron in Figure
4C, showing an average 20 ± 10% increase in synaptic
current during the first 20 sec of ATP application. The remaining two
neurons showed no change. Between 20 and 60 sec, synaptic current
decreased significantly in all cells to 0.84 ± 0.16 of control.
That the inhibitory response had an earlier onset in the whole-cell
relative to whole-nerve recording likely reflects that MNs examined
during whole-cell recording all were located near the surface of the slice, whereas MNs contributing to whole-nerve activity were located at
a variety of depths. Because of the time required for diffusion, ATP
and its metabolites would affect surface cells before deeper cells, and
the inhibition would appear first in the whole-cell recording. Thus, in
two of the six neurons a more rapid onset of the adenosine-mediated
inhibition under whole-cell conditions may have obscured an ATP-induced
potentiation of inspiratory synaptic currents. Alternatively,
inspiratory synaptic currents may not be potentiated by ATP in all XII
MNs. This latter possibility is not inconsistent with our observation
that ATP consistently potentiates XII nerve inspiratory activity
in vitro, because not all XII MNs need to respond with an
increased inspiratory current to account for an increased nerve
activity.
Five XII MNs (three identified as inspiratory) also were examined in
the presence of 1.0 µM bath-applied TTX to confirm
electrophysiologically the presence of postsynaptic ATP receptors.
Neurons were identified as inspiratory or noninspiratory before
application of TTX. Disappearance of XII nerve activity and inspiratory
synaptic currents under voltage clamp and action potentials under
current clamp confirmed adequate incubation in TTX. As shown for one
inspiratory XII MN in Figure 3C, inward currents induced by
ATP (10 mM) were similar in all MNs examined under TTX
conditions. They averaged 89 ± 48 pA in amplitude and were
associated with a significant 9.0 ± 6.0% decrease in input
resistance.
As further confirmation of a postsynaptic effect of ATP on XII MNs, the
distribution of P2X2 receptors within the XII nucleus was
examined immunohistochemically (see below, Fig. 7). In addition, three
inspiratory XII MNs responsive to ATP were labeled with Lucifer yellow
and examined immunohistochemically for P2X2 receptor expression. We focused on P2X2 receptors because (1) the
relatively rapid time course of ATP effects suggested an ionotropic P2X
receptor mechanism, (2) of the P2X receptors, only P2X2
receptors are sensitive to suramin and PPADS antagonism (Buell et al.,
1996 ; Collo et al., 1996 ), and (3) ATP excitation of XII nerve
responses was suramin-sensitive (in vitro responses were
also PPADS-sensitive). As illustrated for one MN (Fig. 4), all three
ATP-sensitive inspiratory XII MNs were double-labeled, indicating
P2X2 receptor immunoreactivity.
Fig. 7.
P2X2R immunostaining in the neonatal
mouse and adult rat XII nucleus. A-C, Transverse
sections through postnatal day 2 neonatal mouse medulla ~100 µm
rostral to obex, showing P2X2R TRITC immunofluorescence (1:100 P2X296ab) at increasing magnification. The
white box outline in B is the region
shown in C to illustrate greater cytoplasmic versus
nuclear staining. D, E, Transverse
sections through adult rat medulla ~100 µm caudal to obex, showing
P2X2 receptor immunoperoxidase staining (1:2000
P2X296ab) of XII MNs. F, G,
Transverse sections through adult rat medulla immediately caudal to
obex, showing P2X2 receptor immunoperoxidase staining of
XII MNs under test conditions (1:4000 P2X2R96ab)
(F) and block of the immunolabeling by
antiserum preadsorbed with its target peptide
(G). Scale bars in A-G represent
100, 50, 10, 100, 20, 150, and 150 µm, respectively. dmx, Dorsal motor nucleus of vagus; XII,
hypoglossal motor nucleus (arrows in
A).
[View Larger Version of this Image (142K GIF file)]
Adenosine mediates post-ATP inhibition of XII nerve burst amplitude
in vitro
To test the hypothesis that the post-ATP inhibition of inspiratory
burst amplitude results from the catabolism of ATP to adenosine and
subsequent activation of P1 receptors, we applied ATP during the last
30 sec of 90 sec theophylline (A1 adenosine antagonist) applications. The tonic excitatory and burst amplitude-potentiating components of the ATP response were enhanced only marginally by theophylline (n = 8; Fig.
5A-C). The post-ATP inhibition of burst amplitude, however, was abolished completely (Fig. 5B,C). At
2 min after the start of a 30 sec ATP application, burst amplitude in
the absence of theophylline (0.85 ± 0.11) was significantly lower
than in the presence of theophylline (1.02 ± 0.08), where it
remained above control (pre-ATP) levels (Fig. 5C).
Fig. 5.
Post-ATP inhibition of inspiratory burst amplitude
results from activation of A1 adenosine receptors.
A, Inhibition of inspiratory burst amplitude after 30 sec application of ATP is blocked (B) by 90 sec
preapplication of theophylline (100 µM).
C, Time course of the changes in XII nerve inspiratory
burst amplitude after local application of ATP (1 mM)
before, during, and after local application of theophylline (100 µM; n = 8); asterisk
indicates significant difference from amplitude values observed at the
same time during the control ATP application. D, Time
course of the changes in XII nerve inspiratory burst amplitude after
local application of adenosine (1 mM; n = 6); asterisk indicates significant difference from
control, pre-ATP levels.
[View Larger Version of this Image (32K GIF file)]
To verify that adenosine could mediate the post-ATP inhibition of burst
amplitude, we applied adenosine locally (1 mM) over XII
motor nuclei for 30 sec. Adenosine caused significant inhibition of
ipsilateral XII nerve inspiratory burst amplitude in all cases (n = 6; Fig. 5D). The maximum decrease in
burst amplitude to 0.77 ± 0.12 of control was reached 1 min after
onset of adenosine application. Burst amplitude then returned to
control levels over the next 10 min.
ATP mediates tonic excitation of XII nerve activity
in vivo
The effects of ATP on XII nerve output also were examined in
vivo. At end-tidal PCO2 5%, robust inspiratory
activity was present on XII and phrenic nerves (Fig.
6A,B,D). Similar to in vitro findings, application of ATP within the XII motor nucleus produced potent excitation of XII nerve output in 13 of 13 sites. The
response was dominated by an increase in tonic discharge, apparent as a
rapid shift in the baseline of the rectified, integrated XII nerve
trace (Fig. 6A,B). In 11 of 13 sites a biphasic
excitatory response was observed in which an initial rapid
depolarization, which peaked within 1 sec, began to decay in 2-3 sec,
giving way to a slower time course excitation that lasted ~30 sec
(Fig. 6Ai,B). Injection into the two remaining sites
elicited a rapid response in one case and a slower response in the
other. Repetitive ATP applications presented at 5 min intervals
produced consistent responses. The excitation was exclusively
ipsilateral, indicating minimum diffusion of ATP away from the
injection site. Blood pressure and heart rate were unaffected.
Suramin, which caused a brief increase in tonic discharge when injected
alone, completely or partially blocked the excitatory effects of ATP in
eight of nine trials (Fig. 6Aii). Full recovery from
suramin block was observed in seven of eight trials (Fig. 6Aiii) after 20-60 min washout. PPADS antagonism of
ATP responses was not examined in vivo because of the
extended periods required for recovery in vitro and the
inability to establish drug concentration within the tissue after local
injection (see Drug Application in Materials and Methods).
In contrast to the uniform potentiation of burst amplitude observed
in vitro, inspiratory burst amplitude was affected minimally by ATP in vivo, increasing in 2 of 13 trials (Fig.
6B). Similarly, the post-ATP decrease in inspiratory
burst amplitude observed in vitro was not observed in
vivo (Fig. 6A,B).
In comparing in vitro versus in vivo
results, it is important to consider that whole XII nerve activity
reflects activity of inspiratory as well as noninspiratory MNs excited
by ATP. Thus, the relative magnitude of the inspiratory potentiation
versus tonic excitation should increase with an increase in the
proportion of inspiratory XII MNs activated by ATP. Consistent with
this hypothesis, application of ATP over the ventromedial inspiratory aspect of the nucleus, but not the dorsal aspect, in vitro
potentiated inspiratory amplitude. Optimal placement of the drug
pipette within inspiratory regions of the XII motor nucleus is more
difficult in vivo. Thus, minimal burst amplitude
potentiation and absence of post-ATP inhibition in vivo may
reflect that ATP and its metabolite, adenosine, primarily activated
noninspiratory MNs.
Therefore, to enhance activation of inspiratory versus noninspiratory
MN pools, inspiratory-related XII MN discharge was recorded extracellularly before ATP injection in two experiments (Fig. 6Cii). Inspiratory-related XII MN discharge was observed in
only a few recording positions at ~1 mm rostral to obex in the
ventromedial part of the nucleus. Injection into the inspiratory
regions identified in this way did not potentiate inspiratory
amplitude.
In addition, end-tidal CO2 was elevated to 5.5% in two
trials to recruit inspiratory XII MNs and thus increase the relative size of the inspiratory MN pool. That elevated CO2
recruited XII MNs during inspiration was suggested by an increase in
integrated XII nerve inspiratory burst amplitude. However, this was not
associated with ATP-induced increases in burst amplitude.
Immunohistochemical and RT-PCR detection of P2X2
receptors in XII motoneurons
To verify further P2 receptor involvement in the XII nerve
responses as well as a postsynaptic site of action, we examined the
distribution of P2X2 receptors within the XII motor nuclei of neonatal mice and adult rats. As described previously, we focused on
P2X2 subunit expression because the speed of the ATP
responses and their suramin/PPADS sensitivity were consistent with
P2X2 receptor activation (Buell et al., 1996 ; Collo et al.,
1996 ). A specific antiserum (P2X2R96; Kanjhan et al., 1996 )
recognizing residues 96-113 of the P2X2 receptor subunit
was used.
Immunostaining was observed throughout the XII motor nuclei of both
neonatal mice (n = 3; Fig.
7A-C) and adult rats (n = 3, Fig. 7D-F). Staining of individual XII MNs was
variable, but, in general, XII MNs in all regions of the nucleus had
densely stained cell bodies and proximal dendrites. There were no
obvious subpopulations of MNs that failed to show immunoreactivity.
Cytoplasmic staining was more intense than nuclear labeling (Fig.
7C,E). Control sections, incubated with PBS without
P2X2 receptor antiserum, showed no evidence of staining
(data not shown). In addition, immunostaining was blocked significantly
by preincubation of antiserum with the target peptide (Fig.
7F,G).
Expression of mRNA for the P2X2 receptor subunit in
micropunches of adult rat XII nucleus is also consistent with ATP
acting via P2X2 receptors (Fig. 8). Direct
sequencing identified three isoforms of the P2X2 subunit.
In addition to the original isoform cloned from PC12 cells [Brake et
al. (1994) , GenBank U14414], two splice variants [Housley et al.
(1995) , GenBank L43511; Brändle et al. (1997) , GenBank Y09910]
were expressed in the hypoglossal nucleus. The two latter
P2X2 isoforms have not been localized previously in the
CNS. Whether a single XII MN expresses all three isoforms remains
unclear because the P2X2 antiserum does not discriminate
among these isoforms. The XII nucleus is a relatively homogeneous
population of cells with few interneurons (Viana et al., 1990 ). Thus,
although the source of the P2X2 mRNA in these experiments
remains equivocal, its most likely source is from XII motoneurons.
Control reactions omitting first-strand cDNA synthesis before PCR
failed to yield PCR products, confirming reaction specificity for
P2X2R mRNA.
Fig. 8.
Identification of mRNA for P2X2
receptor subunit isoforms in micropunches from the hypoglossal nucleus.
A, Dark-field photomicrograph of 240 µm transverse
medullary section showing location of micropunch (arrowhead). B, Ethidium bromide-stained
gel showing the PCR products for three P2X2 receptor
subunit isoforms isolated from the micropunch. Lane 1,
Molecular weight marker ( X174/HaeIII; BRL, Bethesda, MD). Lane 2, The 85 bp insert isoform (Housley et al.,
1995 ) obtained by using primers 1558as/S4. Lane 3,
Isoform (Brake et al., 1994 ) obtained by using primers 1558as/S3.
Lane 4, Isoform (Brändle et al., 1997 ) with 207 bp
exon deletion obtained by using primers 1558as/S1. Lengths of fragments
are indicated on the right. Calibration bar in
A, 1 mm.
[View Larger Version of this Image (86K GIF file)]
DISCUSSION
Mechanisms of ATP-induced excitation
Tonic depolarization
The tonic depolarizing effect of ATP on XII MNs may have several
components, because P2 receptor agonists excite neurons via several
actions. They inhibit (1) a resting K+ current in
central catecholaminergic neurons (Harms et al., 1992 ), (2) a
calcium-sensitive K+ current in myenteric ganglion
cells (Katayama and Morita, 1989 ), and (3) an M-type
K+ current in sympathetic ganglion cells (Akasu et
al., 1983 ). They also activate (1) a nonselective cationic conductance
with a large Ca2+ permeability in cochlear hair
cells (Thorne and Housley, 1996 ), (2) a cationic conductance in rat
sensory neurons (Krishtal et al., 1988 ), and (3)
Ca2+-sensitive Na+ channels and
Ca2+-sensitive nonselective cationic channels in
locus coeruleus neurons (Harms et al., 1992 ). ATP activation of an
inward current via increased conductance in XII MNs (Figs. 3, 4) (as
well as substantia gelatinosa neurons; Li and Perl, 1995 ) is more
consistent with a mechanism involving P2 receptor activation of a
cationic conductance.
The effects of ATP on respiratory-related neurons is unclear. ATP,
acting via P2 receptors, excites putative respiratory and cardiovascular neurons of the nucleus tractus solitarius (Ueno et al.,
1992 ) as well as putative cardiovascular neurons of the rostroventrolateral medulla (Ralevic et al., 1996 ). MNs express mRNA
for several subunits of P2X receptor (Collo et al., 1996 ), but direct
evidence of P2 receptor-mediated excitation of MNs is limited to the
activation of inward currents in MNs dissociated from the dorsal motor
vagus of rat (Ueno et al., 1996 ) and XII MNs in slices from neonatal
mouse (present study). That XII MNs acutely dissociated from rat are
unresponsive to ATP (Ueno et al., 1996 ) is difficult to explain, given
the powerful excitatory effects of ATP on XII MN activity observed in
our study.
Potentiation of hypoglossal inspiratory activity
Inspiratory drive to XII MNs is almost entirely glutamatergic
(Greer et al., 1991 ; Funk et al., 1993 ). Thus, the ATP potentiation of
inspiratory XII nerve and MN activity (Fig. 1) in vitro
supports P2 receptor potentiation of glutamatergic synaptic
transmission. In the substantia gelatinosa ATP not only activates a
fast inward current, it also potentiates glutamate-induced and
synaptically evoked glutamate currents (Li and Perl, 1995 ). Inhibition
of evoked glutamatergic EPSCs and glutamate-induced currents in CA3
pyramidal cells by P2 antagonists also supports purinergic potentiation of glutamatergic synaptic transmission (Motin and Bennett, 1995 ).
Pre- and postsynaptic mechanisms could contribute to this
potentiation. A postsynaptic action of ATP on XII MNs is indicated by
depolarization and decreased input resistance under TTX (Fig. 3).
Reduction of evoked EPSCs and glutamate-evoked currents by suramin and
reactive blue 2 in hippocampal CA3 neurons (Motin and Bennett, 1995 )
and ATP potentiation of glutamate currents and glutamate-evoked EPSCs
in neurons of the substantia gelatinosa (Li and Perl, 1995 ) are also
consistent with postsynaptic P2 receptor potentiation of glutamate
responses.
A presynaptic contribution to potentiation of glutamatergic
transmission, however, cannot be ruled out (Li and Perl, 1995 ). Blocking of evoked glutamate EPSCs in CA3 pyramidal neurons, but not
glutamate-induced currents, by a P2X antagonist suggests endogenous presynaptic potentiation of glutamate release by P2 receptors (Motin
and Bennett, 1995 ).
Receptors mediating effects of ATP
Inhibition of the excitatory effects of ATP on hypoglossal
activity by suramin and PPADS is most consistent with ATP acting on P2
receptors. Suramin inhibition of ectonucleotidase activity (Kennedy et
al., 1996 ) would reduce adenosine production; however, adenosine
inhibits glutamatergic inputs to XII MNs (Fig. 5; Bellingham and
Berger, 1994 ).
The kinetics of the ATP-mediated excitation are consistent with
activation of an ionotropic mechanism. ATP-mediated excitatory responses in XII nerve were substantially faster in onset and shorter
in duration than second-messenger-mediated XII nerve responses elicited
by norepinephrine and TRH in identical slice preparations (Funk et al.,
1994 ). In vivo responses to ATP were even faster (Fig. 6).
The time course data, however, are not conclusive evidence for
involvement of P2X receptors because of the limited temporal resolution
associated with applying drugs over thick tissue. A P2Y contribution
remains possible and may be reflected in the slower time course
excitatory response observed in vivo (Fig. 6Ai,B) and occasionally in vitro.
The sensitivity of ATP-mediated responses to PPADS in the low
micromolar range provides additional support for P2X2
receptor involvement in XII MN excitation by ATP. PPADS has been used
as a specific P2X receptor antagonist in a number of systems (Lambrecht et al., 1992 ; Trezise et al., 1994 ; Ziganshin et al., 1994 ; Connolly, 1995 ). However, the recent description of partial P2Y receptor antagonism by PPADS in aortic endothelial cells (Brown et al., 1995 )
and mesenteric arteries (Windscheif et al., 1994 ; Ralevic and
Burnstock, 1996 ) questions PPADS selectivity for P2X receptors.
Although pharmacological data remain equivocal, specific involvement of
P2X2 receptors in XII MN excitation is supported by (1)
P2X2 mRNA within the XII nucleus (Fig. 8; Collo et al.,
1996 ) and (2) P2X2 receptors on ATP-sensitive inspiratory
XII MNs (Fig. 4). P2X receptor expression within the XII nucleus is
not, however, limited to the P2X2 subunit. P2X2
receptor currents show substantial inward rectification (Brake et al.,
1994 ). Because ATP-gated ion channels are hypothesized to form from
pentameric assembly of subunits, minimal rectification of XII MN
responses to ATP supports heteromeric assembly of P2XR
subunits, possibly involving P2X4 (Séguéla et
al., 1996 ) and P2X6 (Chang et al., 1995 ) subunits. Heteromeric assembly is consistent with in situ
hybridization data (Collo et al., 1996 ) indicating expression of
P2X2, P2X4, and P2X6
receptor subunits on XII MNs.
Mechanisms underlying secondary inhibition
Increases in synaptic adenosine resulting from hydrolysis of ATP
(Gibb and Halliday, 1996 ) primarily inhibit synaptic transmission via
activation of presynaptic A1 receptors (Meriney and
Grinnell, 1991 ; Lupica et al., 1992 ; Prince and Stevens, 1992 ;
Burnstock, 1995 ; Dong and Feldman, 1995 ). The excitatory effects of ATP
on XII nerve output in vitro are associated with a slowly
developing inhibition of inspiratory activity. The secondary depression
may result from diffusion of ATP and activation of nearby inhibitory interneurons (Umemiya and Berger, 1995 ). However, it is more consistent with hydrolysis of ATP to adenosine and P1(A1)
receptor inhibition of glutamatergic activity, as seen in the
substantia gelatinosa (Li and Perl, 1995 ) and striatum (James and
Richardson, 1993 ).
First, excitation of hypoglossal activity was exclusively ipsilateral,
indicating minimal diffusion of ATP. Second, suramin blocked the
excitatory response but had minimal effects on inhibitory response,
consistent with separate receptor mechanisms. Third, the inhibitory
component was blocked by preapplication of the specific A1
adenosine receptor antagonist theophylline (Fig. 5A-C). Fourth, adenosine inhibited XII nerve inspiratory output (Fig. 5D) and glutamatergic inputs to XII MNs (Bellingham and
Berger, 1994 ).
In vitro versus in
vivo experiments
ATP potently excited XII nerve discharge in vitro and
in vivo. The amplitude potentiation present in
vitro, however, was observed only in 2 of 13 trials in
vivo. Similarly, the post-ATP inhibition of inspiratory burst
amplitude was not observed in vivo. Several factors may
contribute to these differences.
The minimal effects, positive or negative, of ATP on burst amplitude
in vivo do not seem to result solely from disproportionate activation of noninspiratory MNs in vivo (see Results).
Attempts to maximize the activation of inspiratory MNs did not enhance amplitude potentiation. It remains possible that longer in
vitro applications of ATP facilitated drug diffusion, activating a
greater portion of the XII MN pool. The higher concentration of ATP
used in vivo also may have obscured amplitude potentiation
through depolarization block.
Alternatively, developmental variation in purinoceptor expression may
contribute to differences between neonatal and adult animals (see Evans
and Surprenant, 1996 ). Reduction in the potentiating effect of ATP in
the adult may reflect a developmental reduction in a receptor subunit
that specifically mediates the inspiratory-potentiating component of
the response. Similarly, the reduction in the post-ATP inhibitory
response may result from developmental variation in degradation and
reuptake systems for ATP and adenosine (Geiger and Nagy, 1990 ).
Postnatal decreases in adenosine receptor expression are unlikely to
contribute because A1 receptor expression within most brain
regions, including the XII motor nucleus, does not decrease postnatally
(Daval et al., 1991 ; Rivkees, 1995 ; Weaver, 1996 ).
Despite the differences between the in vivo and in
vitro responses to exogenous ATP application, it is clear that in
all systems tested ATP potently excites XII nerve activity.
Functional significance of ATP as a transmitter/modulator within
the respiratory motor system
Localization of mRNA for P2X receptor subunits within most cranial
and spinal motor nuclei (Collo et al., 1996 ) implicates a general
function of purinoceptors in controlling motor outflow from the CNS. In
fact, recent evidence indicates purinergic regulation of motor pattern
generation in Xenopus embryos (Dale and Gilday, 1996 ).
A potentially important role for P2 receptor synaptic signaling in
respiratory motor control is suggested by the multiple physiological
effects of ATP on hypoglossal activity reported here; the presence of
P2X2, P2X4, and P2X6
receptor mRNA in nucleus ambiguus and the hypoglossal nucleus (Collo et
al., 1996 ), regions containing upper airway MNs; RT-PCR identification
of ATP receptor isoforms in punches of XII nucleus (Fig. 8); and
immunohistochemical detection of P2X2 receptor protein on
identified inspiratory XII MNs.
The precise function of purinoceptor synaptic signaling in upper airway
control, however, remains unclear. ATP may act as a modulator of
glutamatergic inspiratory drive to XII MNs (Li and Perl, 1995 ).
Colocalization of ATP and NE in locus coeruleus neurons (Nieber and
Illes, 1996 ) is consistent with ATP modulation of inspiratory XII MN
function because the XII nucleus receives NE inputs (Levitt and Moore,
1979 ; Aldes et al., 1992 ) and NE excites XII MNs (Parkis et al., 1995 )
and potentiates inspiratory activity (Funk et al., 1994 ). However,
given that XII MNs also have nonrespiratory functions and that ATP acts
as the principal fast excitatory transmitter at other central synapses
(Edwards et al., 1992 ; Evans et al., 1992 ), ATP also may act as a
synaptic mediator for nonrespiratory inputs to XII MNs.
FOOTNOTES
Received Jan. 22, 1997; revised May 2, 1997; accepted May 9, 1997.
This research was supported by grants from the Auckland Medical
Research Foundation, Health Research Council of New Zealand, Lotteries
Health, Marsden Fund, Neurological Foundation, New Zealand Cot Death
Association, and the Wallath Trust. We thank Drs. D. L. Christie and P. R. Thorne for assistance with the development of P2X2
receptor antibodies and Denise Greenwood for excellent technical
assistance.
Correspondence should be addressed to Dr. G. D. Funk, Department of
Physiology, Faculty of Medicine and Health Science, University of
Auckland, Private Bag 92019, Auckland, New Zealand.
REFERENCES
-
Abbracchio MP,
Burnstock G
(1994)
Purinoceptors: are there families of P2X and P2Y purinoceptors?
Pharmacol Ther
64:445-475[ISI][Medline].
-
Aldes LD,
Chapman ME,
Chronister RB,
Haycock JW
(1992)
Sources of noradrenergic afferents to the hypoglossal nucleus of the rat.
Brain Res Bull
29:931-942[ISI][Medline].
-
Akasu T,
Hirai K,
Koketsu K
(1983)
Modulatory actions of ATP on membrane potentials of bullfrog sympathetic ganglion cells.
Brain Res
258:313-317[ISI][Medline].
-
Balcar VJ,
Li Y,
Killinger S,
Bennett MR
(1995)
Autoradiography of P2X ATP receptors in the rat brain.
Br J Pharmacol
115:302-306[ISI][Medline].
-
Bellingham MC,
Berger AJ
(1994)
Adenosine suppresses excitatory glutamatergic inputs to rat hypoglossal motoneurons in vitro.
Neurosci Lett
177:143-146[ISI][Medline].
-
Blanton MG,
Lo Turco JJ,
Kriegstein AJ
(1989)
Whole-cell recording from neurons in slices of reptilian and mammalian cerebral cortex.
J Neurosci Methods
30:203-210[ISI][Medline].
-
Bo X,
Burnstock G
(1994)
Distribution of [3H]
, -methylene ATP binding sites in rat brain and spinal cord.
NeuroReport
5:1601-1604[ISI][Medline]. -
Brake AJ,
Wagenbach MJ,
Julius D
(1994)
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
Nature
371:519-523[Medline].
-
Brändle U,
Spielmanns P,
Osteroth R,
Sim J,
Surprenant A,
Buell G,
Ruppersberg JP,
Plinkert PK,
Zenner HP,
Glowatzki E
(1997)
Desensitization of the P2X2 receptor controlled by alternative splicing.
FEBS Lett
404:294-298[ISI][Medline].
-
Brown C,
Tanna B,
Boarder MR
(1995)
PPADS: an antagonist at endothelial P2Y purinoceptors but not P2U purinoceptors.
Br J Pharmacol
116:2413-2416[ISI][Medline].
-
Buell G,
Collo G,
Rassendren F
(1996)
P2X receptors: an emerging channel family.
Eur J Neurosci
8:2221-2228[ISI][Medline].
-
Burnstock G
(1995)
Current state of purinoceptor research.
Pharm Acta Helv
69:231-242[Medline].
-
Burnstock G, Sneddon P (1985) Evidence for ATP and
noradrenaline as cotransmitters in sympathetic nerves. Clin Sci
68(Suppl 10):89S-92S.
-
Chang K,
Hanaoka K,
Kumada M,
Takuwa Y
(1995)
Molecular cloning and structural analysis of a novel P2 nucleotide receptor.
J Biol Chem
270:20152-20158.
-
Collo G,
North RA,
Kawashima E,
Merlo-Pich E,
Neidhart S,
Surprenant A,
Buell G
(1996)
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
J Neurosci
16:2495-2507[Abstract/Free Full Text].
-
Connolly GP
(1995)
Differentiation by pyridoxal 5-phosphate PPADS and isoPPADS between responses mediated by UTP and those evoked by
, -methylene ATP on rat sympathetic ganglia.
Br J Pharmacol
114:727-731[ISI][Medline]. -
Dale N,
Gilday D
(1996)
Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos.
Nature
383:259-261[Medline].
-
Daval J-L,
Werck MC,
Nehlig A,
Pereira de Vasconcelos A
(1991)
Quantitative autoradiographic study of the postnatal development of adenosine A1 receptors and their coupling to G-proteins in the rat brain.
Neuroscience
40:841-851[ISI][Medline].
-
Day TA,
Sibbald JR,
Khanna S
(1993)
ATP mediates an excitatory noradrenergic neuron input to supraoptic vasopressin cells.
Brain Res
607:341-344[ISI][Medline].
-
Dong X-W,
Feldman JL
(1995)
Modulation of inspiratory drive to phrenic motoneurons by presynaptic adenosine A1 receptors.
J Neurosci
15:3458-3467[Abstract].
-
Dubyak GR,
El-Moatassim C
(1993)
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
Am J Physiol
265:C577-C606[Abstract/Free Full Text].
-
Edwards FA,
Gibb AJ,
Colquhoun D
(1992)
ATP receptor-mediated synaptic currents in the central nervous system.
Nature
359:144-147[Medline].
-
Evans RJ,
Surprenant A
(1996)
P2X receptors in autonomic and sensory neurons.
Semin Neurosci
8:217-223.
-
Evans RJ,
Derkach V,
Surprenant A
(1992)
ATP mediates fast synaptic transmission in mammalian neurons.
Nature
357:503-505[Medline].
-
Fredholm BB,
Abbracchio MP,
Burnstock G,
Daly JW,
Harden TK,
Jacobsen KA,
Leff P,
Williams M
(1994)
Nomenclature and classification of purinoceptors.
Pharmacol Rev
46:143-156[ISI][Medline].
-
Funk GD
(1996)
Neuromodulation of hypoglossal motor neurons: developmental changes. Symposium. Neural control of breathing: molecular to organismal perspectives.
Physiologist
39:170.
-
Funk GD,
Smith JC,
Feldman JL
(1993)
Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids.
J Neurophysiol
70:1497-1515[Abstract/Free Full Text].
-
Funk GD,
Smith JC,
Feldman JC
(1994)
Development of thyrotropin-releasing hormone and norepinephrine potentiation of inspiratory-related hypoglossal motoneuron discharge in neonatal and juvenile mice in vitro.
J Neurophysiol
72:2538-2541[Abstract/Free Full Text].
-
Geiger JD,
Nagy JI
(1990)
Adenosine deaminase and [3H]nitro-benzyl-thioinosine as markers of adenosine metabolism and transport in central purinergic systems.
In: Adenosine and adenosine receptors (Williams M,
ed), pp 225-288. Clifton, NJ: Humana.
-
Gibb AJ,
Halliday FC
(1996)
Fast purinergic transmission in the central nervous system.
Semin Neurosci
8:225-232.
-
Greer JJ,
Smith JC,
Feldman JL
(1991)
Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat.
J Physiol (Lond)
437:727-749[Abstract/Free Full Text].
-
Harms L,
Finta EP,
Tschöpl M,
Illes P
(1992)
Depolarization of rat locus coeruleus neurons by adenosine 5
-triphosphate.
Neuroscience
48:941-952[ISI][Medline]. -
Housley GD,
Greenwood D,
Bennett T,
Ryan AF
(1995)
Identification of a short form of the P2XR1-purinoceptor subunit produced by alternative splicing in the pituitary and cochlea.
Biochem Biophys Res Commun
212:501-508[ISI][Medline].
-
James S,
Richardson PJ
(1993)
Production of adenosine from extracellular ATP at the striatal cholinergic synapse.
J Neurochem
60:219-227[ISI][Medline].
-
Kanjhan R,
Housley GD,
Thorne PR,
Christie DL,
Palmer DJ,
Luo L,
Ryan AF
(1996)
Localization of ATP-gated ion channels in cerebellum using P2X2R subunit specific antisera.
NeuroReport
7:2665-2669[ISI][Medline].
-
Katayama Y,
Morita K
(1989)
Adenosine 5
-triphosphate modulates membrane potassium conductance in guinea pig myenteric neurones.
J Physiol (Lond)
408:373-390[Abstract/Free Full Text]. -
Kennedy C,
Westfall TD,
Sneddon P
(1996)
Modulation of purinergic transmission by ecto-ATPase.
Semin Neurosci
8:195-199.
-
Kidd EJ,
Grahames CBA,
Simon J,
Michel AD,
Barnard EA,
Humphrey PPA
(1995)
Localization of P2X purinoceptor transcripts in the rat nervous system.
Mol Pharmacol
48:569-573[Abstract].
-
Krammer EB,
Rath T,
Lischka MF
(1979)
Somatotopic organization of the hypoglossal nucleus: a HRP study in the rat.
Brain Res
170:533-537[ISI][Medline].
-
Krishtal OA,
Marchenko SM,
Obukhov AG
(1988)
Cationic channels activated by extracellular ATP in rat sensory neurones.
Neuroscience
27:995-1000[ISI][Medline].
-
Lambrecht G,
Friebe T,
Grimm U,
Windscheif U,
Bungardt E,
Hildebrandt C,
Baumert HG,
Spatz-Kumbel G,
Mutschler E
(1992)
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
Eur J Pharmacol
217:217-219[ISI][Medline].
-
Levitt P,
Moore RY
(1979)
Origin and organization of brainstem catecholamine innervation in the rat.
J Comp Neurol
186:505-528.
-
Li J,
Perl E
(1995)
ATP modulation of synaptic transmission in the spinal substantia gelatinosa.
J Neurosci
15:3357-3365[Abstract].
-
Liu G,
Feldman JL,
Smith JC
(1990)
Excitatory amino acid-mediated transmission of inspiratory drive to phrenic motoneurons.
J Neurophysiol
64:423-436[Abstract/Free Full Text].
-
Lupica CR,
Proctor WR,
Dunwiddie TV
(1992)
Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording.
J Neurosci
12:3753-3764[Abstract].
-
Meriney SD,
Grinnell AD
(1991)
Endogenous adenosine modulates stimulation-induced depression at the frog neuromuscular junction.
J Physiol (Lond)
443:441-455[Ab
|